GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 381 filers reported holding GUARDANT HEALTH INC in Q3 2021. The put-call ratio across all filers is 0.73 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $452,130 | -79.5% | 15,254 | -75.2% | 0.00% | -77.8% |
| Q2 2023 | $2,202,131 | +112.3% | 61,512 | +39.0% | 0.01% | +350.0% |
| Q1 2023 | $1,037,126 | +22.7% | 44,246 | +42.4% | 0.00% | -60.0% |
| Q4 2022 | $845,049 | -27.5% | 31,068 | +43.6% | 0.01% | -64.3% |
| Q3 2022 | $1,165,000 | +88.5% | 21,633 | +41.2% | 0.01% | +100.0% |
| Q2 2022 | $618,000 | -45.0% | 15,316 | -9.7% | 0.01% | -58.8% |
| Q1 2022 | $1,123,000 | -27.3% | 16,952 | +9.8% | 0.02% | -26.1% |
| Q4 2021 | $1,544,000 | -19.0% | 15,433 | +1.2% | 0.02% | -45.2% |
| Q3 2021 | $1,906,000 | +1.4% | 15,247 | +0.7% | 0.04% | +2.4% |
| Q2 2021 | $1,879,000 | -18.0% | 15,134 | +0.8% | 0.04% | -24.1% |
| Q1 2021 | $2,292,000 | +23.1% | 15,012 | +3.9% | 0.05% | -10.0% |
| Q4 2020 | $1,862,000 | +12.6% | 14,449 | -2.3% | 0.06% | -11.8% |
| Q3 2020 | $1,653,000 | +62.4% | 14,787 | +11.4% | 0.07% | -1.4% |
| Q1 2019 | $1,018,000 | – | 13,279 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |